111 related articles for article (PubMed ID: 28360236)
1. Spin in RCTs of anxiety medication with a positive primary outcome: a comparison of concerns expressed by the US FDA and in the published literature.
Beijers L; Jeronimus BF; Turner EH; de Jonge P; Roest AM
BMJ Open; 2017 Mar; 7(3):e012886. PubMed ID: 28360236
[TBL] [Abstract][Full Text] [Related]
2. Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.
Roest AM; de Jonge P; Williams CD; de Vries YA; Schoevers RA; Turner EH
JAMA Psychiatry; 2015 May; 72(5):500-10. PubMed ID: 25806940
[TBL] [Abstract][Full Text] [Related]
3. Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials.
de Vries YA; Roest AM; Turner EH; de Jonge P
Psychol Med; 2019 Sep; 49(12):2020-2026. PubMed ID: 30261934
[TBL] [Abstract][Full Text] [Related]
4. Selective publication of antidepressant trials and its influence on apparent efficacy.
Turner EH; Matthews AM; Linardatos E; Tell RA; Rosenthal R
N Engl J Med; 2008 Jan; 358(3):252-60. PubMed ID: 18199864
[TBL] [Abstract][Full Text] [Related]
5. Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials.
Turner EH; Cipriani A; Furukawa TA; Salanti G; de Vries YA
PLoS Med; 2022 Jan; 19(1):e1003886. PubMed ID: 35045113
[TBL] [Abstract][Full Text] [Related]
6. Changes to registration elements and results in a cohort of Clinicaltrials.gov trials were not reflected in published articles.
Pranić S; Marušić A
J Clin Epidemiol; 2016 Feb; 70():26-37. PubMed ID: 26226103
[TBL] [Abstract][Full Text] [Related]
7. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
[TBL] [Abstract][Full Text] [Related]
8. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.
Rising K; Bacchetti P; Bero L
PLoS Med; 2008 Nov; 5(11):e217; discussion e217. PubMed ID: 19067477
[TBL] [Abstract][Full Text] [Related]
9. Research misconduct identified by the US Food and Drug Administration: out of sight, out of mind, out of the peer-reviewed literature.
Seife C
JAMA Intern Med; 2015 Apr; 175(4):567-77. PubMed ID: 25664866
[TBL] [Abstract][Full Text] [Related]
10. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
Hart B; Lundh A; Bero L
BMJ; 2012 Jan; 344():d7202. PubMed ID: 22214754
[TBL] [Abstract][Full Text] [Related]
11. Suicide rates in short-term randomized controlled trials of newer antidepressants.
J Clin Psychopharmacol; ; . PubMed ID: 16633153
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
